Aims: 1. To quantify barriers to alcohol screening among hypertensive patients reported by primary healthcare professionals. 2. To examine whether education and screening frequency measures are associated with stigma-related barriers. Methods: A web survey was conducted among 3081 primary healthcare professionals from France, Germany, Italy, Spain and the UK. Participants were asked about perceived barriers to alcohol screening as free-text response. The replies were independently categorized by two raters. Stigma-related barriers were predicted by logistic regressions with education, knowledge on alcohol as risk factor and frequency of alcohol screening. Results: In France and Italy, almost half of the reported barriers were stigma-related, whereas time constraints were cited most commonly in Spain and the UK. In Germany, nearly half of
INTRODUCTION
Alcohol use is considered one of the main risk factors for disease burden worldwide (GBD 2015 Risk Factors Collaborators, 2016 . In order to reduce adverse public health effects of alcohol, screening and brief interventions (SBI) in primary healthcare settings have been identified as (cost-) effective means (World Health Organization, 2010; O'Donnell et al., 2014; OECD, 2015) . However, implementation has progressed rather slowly (Colom et al., 2014) , reflected by low screening rates in Europe (Rehm et al., 2016) , and less than half of patients with hazardous drinking levels are identified by their general practitioners (GPs) (Manthey et al., 2015) . Thus, a considerable gap between study recommendations and daily clinical practice remains (McCormick et al., 2010) . In order to facilitate implementation and to enhance acceptance of SBI, an increased focus on the primary healthcare professionals' daily routine and their perception of barriers in the management of alcohol was proposed (McCormick et al., 2010) . This pragmatic bottom-up approach should also identify core elements of SBI and help to integrate these elements into the current practice.
Several studies have identified a recurring pattern of barriers to alcohol screening in primary healthcare (for a systematic review of qualitative studies, see Johnson et al. (2011) ): overall, GPs commonly found it inappropriate to screen for alcohol in every single patient (Beich et al., 2002; Aira et al., 2003; Johansson et al., 2005; Nygaard and Aasland, 2011) and reported lack of time (Beich et al., 2002; Aira et al., 2003; Mules et al., 2012; Drummond et al., 2013) and financial reimbursement (Nygaard and Aasland, 2011; Schulte et al., 2014) . Moreover, some GPs found it difficult to implement screening into existing routines (Beich et al., 2002; Aira et al., 2003; Nygaard and Aasland, 2011) . However, screening was more accepted if patients present with alcoholrelated symptoms (Johansson et al., 2005) or if their consulting reason was associated with alcohol, such as for sleeplessness and hypertension (Aira et al., 2003; Nygaard and Aasland, 2011) . Moreover, stigmatization of alcohol misuse appears to hinder screening (Beich et al., 2002; Aira et al., 2003; Johansson et al., 2005; Nygaard and Aasland, 2011; Mules et al., 2012) . Further barriers related to sociodemographic characteristic of the patient (Beich et al., 2002; Johansson et al., 2005; Mules et al., 2012) , but also to lacking training, skills or expertise (Johansson et al., 2005; Mules et al., 2012; Schulte et al., 2014) .
Given the above, hypertension seemed an interesting case to study, as it is strongly impacted by alcohol use (Taylor et al., 2009) , its treatment is well established in primary healthcare, and alcohol screening is recommended for hypertension management (National Institute for Health and Clinical Excellence, 2011b). The primary aim of this study was to present the distribution of perceived barriers for alcohol screening among hypertensive patients in a sample of primary healthcare professionals from the largest European countries.
The secondary aim was to identify the role of stigma as a barrier to alcohol screening. Stigma describes a social process in which members of low status groups are labeled, negatively stereotyped, marginalized and discriminated against (Link and Phelan, 2001 ). Research suggests that there is a particularly severe stigma attached to alcohol use disorders, compared with other mental health conditions (Schomerus et al., 2011) . Public perceptions of people with alcohol use disorders involve negative labels such as dangerous, unpredictable or immoral, resulting in an elevated risk for social rejection and discrimination (Room, 2005; Schomerus et al., 2011) . As such, stigma can impact on the interaction between GP and patient when treating alcohol-related issues. Individuals in healthcare settings may try to conceal their alcohol consumption in order to avoid stigmatization (Keyes et al., 2010; Corrigan et al., 2017) . Indeed, GPs reported that they perceived stigma to affect their patients' behavior as they would refuse to speak about their drinking or underreport or deny any drinking (Beich et al., 2002; Nygaard and Aasland, 2011; Mules et al., 2012) . Further, GPs may avoid alcohol-related discussions due to the negative labels attached to alcohol misuse. In several studies, GPs linked difficulties or discomfort they had experienced when discussing alcohol consumption with their patients to stigma (Nygaard and Aasland, 2011; Mules et al., 2012) .
Previous research has indicated that education, increased knowledge and personal contacts with members of stigmatized groups can contribute to reduce stigma (Miller et al., 2006; Corrigan et al., 2012; Livingston et al., 2012) . Consequently, we hypothesized that the occurrence of stigma-related barriers is negatively related to the GPs' education on alcohol, their perception of alcohol as risk factor for hypertension, and the frequency of screening as an indicator for personal contact. In order to contextualize and to better understand the extent of GPs' alcohol-related education, we sought to compare it to their education on hypertension.
METHODS

Study Design
For the purpose of this study, a questionnaire was developed by researchers and GPs with expertise in primary healthcare and alcohol. A first draft in English language was piloted among 41 GPs and subsequently condensed to 28 items (in addition to some countryspecific items) in its final form. Translations were disseminated among primary healthcare professionals from France, Germany, Italy, Spain, and the UK as online survey via national (France, Italy, Spain, UK) or regional GP (Germany: Hamburg and Bavaria) associations in the respective countries. The survey made no mention of alcohol in the title or its description in order to avoid losing respondents being uncomfortable with this (stigmatized) topic. All data were collected between September and December 2015 and duplicates were removed from the final sample. More details on the questionnaire and study design can be found in previous reports of this study (Rehm et al., 2016; Kraus et al., 2017) .
Variables
To identify barriers to alcohol screening (first aim), GPs indicating infrequent alcohol screening in patients with hypertension (at most 3 out of 10 patients) were prompted to specify any reasons for not screening in an open format ('What are the main barriers to screening for alcohol use, hazardous drinking or alcohol dependence?'). Responses from the German and British sample were then used by J.M. to inductively derive a classification system for the answers (see Web Table for details and exemplary responses). All responses were subsequently classified into the given categories by two independent raters, with the option to expand the classification system by own categories if needed. With regards to stigma-related barriers, the classification system recommended including responses indicating that alcohol use is difficult to discuss, that patients would not like to talk about it or would not give truthful answers, or that patients would be in denial. The agreement of both raters was assessed using Cohen's kappa (κ) and disagreements were revisited and decided by J.M.
To examine whether occurrence of stigma-related barriers was related to the GPs' education, knowledge, and screening frequency (second aim), we referred to the following survey questions: (1) Educational attainment regarding alcohol was assessed by rating university education ('Did you find your education at university dealt sufficiently with the topics of alcohol, alcohol use disorders and health?') using a 5-point Likert scale ('The topic was covered: not at all-very sufficiently'). Another measure of educational attainment was obtained by assessing the respondents' postgraduate training on a binary scale ('Did you have any postgraduate training for dealing with hazardous drinking or alcohol dependence?'). The same questions were also applied to assess the educational attainment regarding hypertension. (2) Knowledge on alcohol as risk factor for hypertension was assessed via importance ('Please select the three most important risk factors for hypertension: lack of physical activity; diet with high salt intake; alcohol use; smoking; overweight and obesity; stress; sleep apnea') and ability to manage these ('Thinking of your patients, which of the risk factors for hypertension could be most easily dealt with by a GP? Pick two risk factors that are easiest to address for GPs.'). (3) Screening frequency was assessed by recording the number of hypertensive patients screened for alcohol (see question above, range: 0 to 3 out of 10 patients screened).
As a result, we derived each one ordinal (sufficiency of university education) and one binary (postgraduate education) variable representing educational attainment regarding alcohol and hypertension, two binary variables on alcohol as risk factor for hypertension (importance and manageability), and one continuous variable containing the number of screens conducted (0-3). Further, an additional binary index variable was created for each alcohol and hypertension education, by collapsing respective respondents with sufficient graduate (at least 4 out of 5 points on Likert scale) or any postgraduate education (binary variable).
Statistical Analysis
All analyses were performed on country-specific subsamples as healthcare systems are fairly diverse (Drummond et al., 2013; Colom et al., 2014) and implementation of SBI should be tailored to local needs (McCormick et al., 2010) . For the first research question, a descriptive distribution of barriers to alcohol screening and of indicators for education, knowledge, and screening frequency were presented for each country. In this set of variables, post-hoc tests examined whether specific countries differ from the remaining sample following Omnibus-tests, which tested for overall differences across all countries. For binary measures (i.e. all barriers, postgraduate education, education index, importance and manageability of alcohol as risk factor), we performed Chi 2 -tests (as omnibus and post-hoc tests), while graduate education responses (ordinal scale) were examined using Kruskal-Wallis (Omnibus-test) and Wilcoxon rank sum tests (post-hoc tests). The number of screens conducted (continuous response) was analyzed using ANOVA and subsequent t-tests. As multiple tests were run using the same sample, we adjusted the P-level accordingly (Bonferroni-correction). To test for overall and country-specific differences between education on alcohol and hypertension, the composite index variables were compared using McNemars' exact mid-p test.
For the second research question, four country-stratified logistic regressions predicted the occurrence of stigma-related barriers with (A) graduate or postgraduate education on alcohol (index variable), (B) importance and (C) manageability of alcohol within hypertension treatment, as well as (D) number of conducted screens as single predictors. In addition, one country-stratified composite model (E) including all independent variables was conducted, with Bonferroniadjusted p-levels. All analyses were conducted with Stata 14.0 (StataCorp, 2015) .
Ethics Approval and Consent to Participate
This study is based on an anonymous survey, which was exempt from respective research ethics committee approval in all respective countries. As all respondents were presented a brief description of the aims of the study before the actual survey started, consent to participate was a precondition of taking the survey.
RESULTS
The online survey was accessed by 3,081 respondents, which represents 5.7% of all contacted health professionals. The completion rate amounted to 80% (N = 2,468) with most completed surveys in Spain (36.4%), followed by France (20.8%), the UK (20.6%), Italy (14.6%) and Germany (7.7%). Most respondents were women (55.0%) and GPs (89.3%; other professions: internists, cardiologists, nurses, other health professionals), and the age-group 50 to 59 years had the highest proportion (34.6%).
A (3) inappropriateness (e.g. due to other reasons for patient visit, Muslim faith), (4) alcohol use or problems already known (through previous visits or high confidence that it would be told by patients themselves), (5) neglected significance (alcohol use considered as unimportant, other risk factors more important), (6) screening methods unknown/unreliable, (7) stigma (alcohol use difficult to discuss, dishonest answers, denial), (8) other reasons. Interrater agreements of classifying responses into these categories was substantial for screening not being worth the effort (κ = 0.68), inappropriateness (κ = 0.64), alcohol use/problems already known (κ = 0.73), neglected significance (κ = 0.76) and unknown/unreliable screening methods (κ = 0.62). For time constraints (κ = 0.98) and stigma-related barriers (κ = 0.92), almost perfect agreements were observed, while classification of other barriers was less concordant (κ = 0.50). For very few Spanish (N = 9) replies, two new categories were assigned but omitted in this analysis. The distribution of barriers by region is presented in Table 1 . Barriers were distributed unequally across respondents from various European countries: In France and Italy, the most cited barrier to alcohol screening was stigma (e.g. 'refusal of the patient to speak about it'; 'alcohol consumption is considered normal and if investigated patients feel labeled as alcoholic'), whereas time constraints were reported most frequently by Spanish and British respondents. In Germany, primary healthcare professionals' main reason not to screen for alcohol use was that its significance has not been acknowledged (e.g. 'relationship between alcohol dependence and hypertension was not of primary importance to me until now'). Table 2 presents country-stratified measures of education, knowledge, and screening frequency. Significant country-differences were found for most measures. Comparing ratings on hypertension and alcohol education using the index variable, results suggest that professional education for alcohol was consistently poorer than for hypertension (mid-p test for each country: P < 0.001).
With All indicators for education, knowledge, and screening frequency were found to be unrelated to the occurrence of stigma-related barriers in each country as indicated in Table 3 . The results from the logistic regressions did not produce any unambiguous trends for each of the predictors. In contrast, in the composite model using French respondents screening frequency was positively related to the occurrence of stigma-related barriers, indicating that respondents who screened more often reported more stigma-related barriers.
DISCUSSION
Primary healthcare professionals from the largest five EU countries responded to an online questionnaire. This study sought (1) to quantify the barriers to screening for alcohol among patients with hypertension and (2) to examine whether occurrence of stigma-related barriers is associated with alcohol-related education, knowledge or screening frequency.
Aim 1: Reported Barriers
The reported barriers to alcohol screening have already been identified in previous studies (Johnson et al., 2011) . To overcome some of these barriers (e.g. neglected significance, unknown screening tools), education may play a key role. In the examined sample, under-and postgraduate education on alcohol use was lacking and the impact of alcohol intake on blood pressure was underrated. Thus, alcohol may not be given sufficient attention by health professionals. This Table 1 . Distribution of barriers to alcohol screening among patients with hypertension by country Time constraints, % (95% CI) 7.1 (4.8-10.4)* 14.1 (7.6-24.2)* 14.7 (9.6-21.9)* 49.2 (42.9-55.5)* 73.7 (65.8-80.4)* Not worth the effort, % (95% CI) 16.3 (12.8-20.5)* 4.2 (1.0-12.2) 5.4 (2.5-11.0) 3.3 (1.6-6.5)* 2.9 (0.9-7.5) Inappropriateness, % (95% CI) 4.6 (2.8-7.3) 4.2 (1.0-12.2) 0.8 (0.0-4.7) 3.3 (1.6-6.5) 7.3 (3.9-13.1) Alcohol use/problems known, % (95% CI) 1.4 (0.5-3.4)* 16.9 (9.8-27.4)* 5.4 (2.5-11.0) 4.2 (2.2-7.6) 2.9 (0.9-7.5) Neglected significance, % (95% CI) 3.1 (1.7-5.6)* 45.1 (34.0-56.6)* 27.1 (20.2-35.4)* 26.7 (21.5-32.6)* 16.1 (10.8-23.2) Screening methods unknown/unreliable, % (95% CI) 3.1 (1.7-5.6) 9.9 (4.6-19.3) 10.1 (5.9-16.6)* 2.1 (0.8-4.9) 2.9 (0.9-7.5) should be particularly stressed for Italy, as education on alcohol and ratings of importance and manageability of alcohol were lowest among Italian respondents (see also Gandin and Scafato (2013) ). One recurring barrier concerns the adequacy of screening tools, which was already questioned in previous studies (Johansson et al., 2005) . Short questionnaires clearly have disadvantages, including (intentional) under-reporting or memory bias (Greenfield and Kerr, 2008 ). Yet, brief questionnaires such as the AUDIT(-C) are accurate means to assess drinking levels and to identify alcohol use disorders in different populations (Berner et al., 2007) . They are recommended for routine implementation by current guidelines (e.g. Germany (Mann et al., 2016) , Spain (Pastor et al., 2013) , the UK (National Institute for Health and Clinical Excellence, 2011a)). In this study, limited knowledge about screening tools was mainly reported by German and Italian respondents confirming previous findings on low familiarity with screening tools in these countries (Drummond et al., 2013) . However, it should be acknowledged that this barrier was not the primary driver to refrain from screening in this sample.
Some GPs justified infrequent screenings with a general feeling of being well informed or with a belief of patients initiating discussions on this topic themselves if necessary. While this perspective implies a solid patient-doctor rapport, it is in sharp contrast to other respondents' fear to damage this rapport by speaking about alcoholrelated issues. Moreover, it also opposes the difficulty to disclose drinking patterns and quantities and denial of alcohol-related problems-a core aspect of alcohol use disorders (American Psychiatric Association, 2013) . Thus, those GPs may risk missing out patients with excessive alcohol use. This perception mainly affects German respondents. A more thorough examination of this phenomenon accompanied by strategies to prevent or reduce negligence of alcohol issues seems necessary.
In France and Italy, stigma-related barriers prevailed, but not so in other countries. The observed pattern may be partially explained by contextual differences in social norms regarding tolerable levels of alcohol consumption, which may impact on the perceived acceptability of screening about alcohol use among GPs Lid et al., 2015) . For example, the traditional drinking culture in Mediterranean countries appears to approve of alcohol consumption, but not any alcohol-attributable problems such as alcohol use disorders (Allamani, 2008; Rehm et al., 2013) . However, stigma was mentioned less often by Spanish respondents, despite sharing a similar drinking culture. Advances in the integration of alcohol management in primary healthcare in Spain (Drummond et al., 2013; Colom et al., 2014) may have enhanced capabilities of Spanish healthcare professionals to deal with stigma-related problems occurring in treatment routines. It should be noted the relatively low occurrence of stigma-related barriers to alcohol screening in our sample does not necessarily imply that hazardous alcohol use is a straightforward subject to discuss between GPs and patients. On the contrary, in contexts where alcohol consumption is widely accepted, GPs who raise the subject of hazardous alcohol use may be perceived as 'problematizing' a socially sanctioned behavior . Overall, routine screening appears to be highly accepted, as the majority of respondents reported screening at least 4 out of 10 hypertensive patients for alcohol use. Among the remaining respondents, only few questioned the relevance of screening (e.g. not worth the effort, inappropriateness, neglected significance). In order to foster SBI in primary healthcare, country-specific strategies should acknowledge the respective dominating barriers. Based on our findings, German respondents may benefit from educational programs addressing screening as they commonly questioned the relevance of routine screening and were unfamiliar with appropriate screening instruments (Kraus et al., 2017) . In contrast, implementation of SBI in Spain and the UK appears already to be comparably progressive (Drummond et al., 2013; Gandin and Scafato, 2013; Colom et al., 2014; Rehm et al., 2016) and further improvements may require allocating more resources as respondents in these countries often cited structural barriers-such as time constraints-to routine alcohol screening.
Aim 2: Moderators of Stigma
Direct recommendations for tackling stigma in primary healthcare cannot be deduced from our findings because hypothesized associations between stigma-related screening barriers and measures of education and knowledge, as well as screening frequency could not be established. One model suggests a positive link between the occurrence of screening frequency and stigma-related barriers, but a clear pattern across all countries could not be observed for any of the examined predictors. Thus, we cannot confirm the beneficial effects of education and personal contacts to reduce stigma as suggested by previous studies (e.g. a systematic review for substance use disorders (Livingston et al., 2012) ) but future studies can learn from our results nonetheless.
First, the classification of various stigma aspects into a single category may have been too broad: For instance, education could have actually increased GPs' sensitivity towards alcohol-related issues, but not their screening behavior and even less their patients' fear to be stigmatized, resulting in dishonesty or denial. Therefore, diverging stigma perception between doctors and patients should be acknowledged when describing complex patient-doctor interactions. We hence suggest that future studies should differentiate between manifestations of stigma within the patient (denial, minimization of consumption) and manifestations of stigma within the GP (e.g. negative stereotypes, fear of disturbing rapport with the patient) in order to facilitate detection of potential effects.
Second, the positive association between screening frequency and occurrence of stigma-related barriers, as shown in the French subsample, might be explained by negative feedback resulting from inquiries for alcohol use. It seems likely that how this topic is addressed plays a considerable role: An open, sensitive approach might improve rapport, while a rather insensitive, confrontational approach with standardized screening questions might lead to the opposite. This is likely to play a role when strong societal stigma inhibits open discussions. Further research on this potential moderator of the association between the occurrence of stigma-related screening barriers and screening frequency could inform development of screening tools and training programs.
The inconclusive results of this study regarding moderators of stigma in the context of alcohol screening also reflect the complexity of factors that can influence manifestations of alcohol-related stigma within the doctor-patient relationship. Hence, the factors identified in this study should be examined in interaction with other individual and situational circumstances that have been shown to affect screening behavior, such as social norms, GPs own drinking behavior or characteristics of the patient, like gender or socioeconomic status (Aira et al., 2003; Kaner et al., 2006; Geirsson et al., 2009 ).
Limitations
The study design aimed at a representative sample of GPs but the low survey response rate limits the generalizability of the findings. It can be assumed that the survey was taken only by GPs with an interest in the topic of this study. Further, insignificant results do not allow separating support for the null hypothesis from data insensitivity for meaningful effects (Dienes, 2014) .
Moreover, it should be acknowledged that screening barriers were only reported by respondents who practice screening infrequently. We cannot rule out that health professionals with a more regular screening practice differ in their experience of barriers to alcohol screening.
Furthermore, the categories derived from the data should not be considered mutually exclusive. As suggested by others, problems related to the implementation of SBIs in routine healthcare can be viewed as dynamic outcomes of overlapping inter-and intrapersonal as well as contextual factors (Nilsen et al., 2008; Nygaard and Aasland, 2011) . However, despite potentially overlapping categories, interrater agreement for classifying barriers was substantial in this study.
Lastly, the cross-sectional study design is not well-suited for detecting training effects (graduate or postgraduate education) in a heterogeneous sample without controlling neither for type and quality of the training nor for a potential memory bias.
Bottom Line
Despite indicated limitations, this study has several key findings. First, regular alcohol screening among hypertensive patients is largely accepted and practiced in most countries, at least for the sample examined, which probably consisted of primary healthcare practitioners with an interest in hypertension. Second, screening practice is perceived to be limited by time constraints, stigma and perceived low importance of alcohol use, with large variations between the examined countries. Attempts to foster routine screening practice should acknowledge beliefs and perceptions, while findings from this study may help to tailor improved local strategies. Third, respondents' fear and their patients' rejection appear to be relevant issues among French and Italian respondents. To date, effective interventions in reducing stigma using educational means have been reported (Livingston et al., 2012) . While we cannot confirm associations between education and stigma, we have identified a large potential in professional training on alcohol. This could be addressed by further education, aiming to enhance GPs' capabilities to deal with alcohol-related stigma. Experiences from Germany, Spain, and the UK might be useful starting points as stigma was cited comparably rarely here.
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